ExLibris header image
SFX Logo
Title: Effect of oxprenolol and metoprolol on serum lipid concentration
Source:

European Journal of Clinical Pharmacology [0031-6970] Ferrara, L A yr:1984


Collapse list of basic services Basic
Full text
Full text available via SpringerLINK Contemporary 1997-Present
GO
Full text available via SpringerLink Historical Archives Biomedical and Life Sciences
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Gugler, R. "Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension." European journal of clinical pharmacology 27.5 (1984): 529-34. Link to Full Text for this item Link to SFX for this item
2. "Calcium antagonists and thiazide diuretics in the treatment of hypertension." Journal of cardiovascular pharmacology. 10 Suppl 10. Link to SFX for this item
3. Verhaegen, J. "Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol." Angiology 41.2 (1990): 95-105. Link to Full Text for this item Link to SFX for this item
4. "Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities." Diabetes : a journal of the American Diabetes Association. 47.4: 660-667. Link to SFX for this item
5. Erikssen, J. "Comparison of beta-adrenoceptor blockers under maximal exercise (pindolol v metoprolol v atenolol)." British journal of clinical pharmacology 13.Suppl 2 (1982): 201-209. Link to Full Text for this item Link to SFX for this item
6. GUGLER, G. "SINGLE AND MULTIPLE DOSE PHARMACOKINETICS OF PINDOLOL." European Journal of Clinical Pharmacology 13.1 (1978): 13-16. Link to Full Text for this item Link to SFX for this item
7. DHATARIYA, R C. "THE EFFECT OF THE BETA-ADRENOCEPTOR ANTAGONIST PINDOLOL ON EXERCISE PERFORMANCE." British journal of clinical pharmacology 13.5 (1982): 723-727. Link to Full Text for this item Link to SFX for this item
8. Vukovich, R A. "Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate)." British journal of clinical pharmacology 7 Suppl 2.S2 (1979): 167-172. Link to SFX for this item
9. Woods, K L. "Exercise responses of healthy subjects in the evaluation of cardioselectivity ofβ-blockers." European journal of clinical pharmacology 15.4 (1979): 229-233. Link to Full Text for this item Link to SFX for this item
10. "Platelet-Activating Effect of Low-Density Lipoprotein and Its Reversal by Isradipine." American journal of hypertension. 4.2_Pt_2. Link to SFX for this item
11. Gugler, R. "The effect of pindolol on exercise-induced cardiac acceleration in relation to plasma levels in man." Clinical pharmacology & therapeutics : CPT. 17.2: 127-133. Link to SFX for this item
12. Kostis, John B. "Atenolol, nadolol, and pindolol in angina pectoris on effort: Effect of pharmacokinetics." The American heart journal 108.4 (1984): 1131-1136. Link to Full Text for this item Link to SFX for this item
13. Hawkins, Nathaniel M. "Heart Failure and Chronic Obstructive Pulmonary Disease: The Quandary of Beta-Blockers and Beta-Agonists." Journal of the American College of Cardiology 57.21 (2011): 2127-38. Link to SFX for this item
14. FOERSTER, E. "ATENOLOL VERSUS PINDOLOL - SIDE-EFFECTS IN HYPERTENSION." European Journal of Clinical Pharmacology 28.1 (1985): 89-91. Link to Full Text for this item Link to SFX for this item
15. CRUICKSHANK, J. "THE CLINICAL IMPORTANCE OF CARDIOSELECTIVITY AND LIPOPHILICITY IN BETA-BLOCKERS." The American heart journal 100.2 (1980): 160-178. Link to Full Text for this item Link to SFX for this item
16. Brodde, O E E. "Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure." Pharmacological reviews 43.2 (1991): 203-42. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced